We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

74 hedge funds and large institutions have $75.8M invested in Marker Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

471% more call options, than puts

Call options by funds: $2.53M | Put options by funds: $443K

33% more capital invested

Capital invested by funds: $56.8M → $75.8M (+$19M)

0.07% more ownership

Funds ownership: 3.2% → 3.27% (+0.07%)

0% more funds holding

Funds holding: 74 → 74 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

32% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 25

Holders
74
Holders Change
–
Holders Change %
0%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
17
Reduced
25
Closed
16
Calls
$2.53M
Puts
$443K
Net Calls
+$2.09M
Net Calls Change
+$1.47M

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.19M
2
Millennium Management
Millennium Management
New York
+$3.01M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2.35M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.59M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.05M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.79M
2
KCM
Kennedy Capital Management
Missouri
-$3.18M
3
State Street
State Street
Massachusetts
-$1.01M
4
Northern Trust
Northern Trust
Illinois
-$580K
5
N
Nuveen
North Carolina
-$431K
Name Holding Trade Value Shares
Change 		Change in
Stake
ISL
51
Ingalls & Snyder LLC
New York
$43K – – –
LP
52
LMR Partners
United Kingdom
$40K +$37.9K +1,439 New
US Bancorp
53
US Bancorp
Minnesota
$37K – – –
AWP
54
Ascent Wealth Partners
New York
$29K – – –
TRCT
55
Tower Research Capital (TRC)
New York
$28K -$60K -2,279 -70%
UBS Group
56
UBS Group
Switzerland
$25K -$22.3K -847 -49%
APA
57
American Portfolios Advisors
New York
$24.2K – – –
EVM
58
Eaton Vance Management
Massachusetts
$23K – – –
FIA
59
FNY Investment Advisers
New York
$16K -$29K -1,100 -65%
Wells Fargo
60
Wells Fargo
California
$10K -$18.6K -706 -65%
Barclays
61
Barclays
United Kingdom
$9K +$8.93K +339 New
TWM
62
Tradition Wealth Management
Minnesota
$7K +$6.63K +252 New
JP Morgan Chase
63
JP Morgan Chase
New York
$4K -$95.4K -3,624 -97%
Royal Bank of Canada
64
Royal Bank of Canada
Ontario, Canada
$4K -$11.7K -446 -74%
CAPTRUST Financial Advisors
65
CAPTRUST Financial Advisors
North Carolina
$3K – – –
PWM
66
Prentice Wealth Management
New York
$3K – – –
HNB
67
Huntington National Bank
Ohio
$2K – – –
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$1.29K -$13.4K -508 -92%
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$1K -$36.2K -1,375 -98%
TWA
70
TCI Wealth Advisors
Arizona
$1K -$1.32K -50 -71%
JCM
71
Jacobi Capital Management
Pennsylvania
$1K – – –
N
72
Nuveen
North Carolina
– -$431K -19,257 Closed
Simplex Trading
73
Simplex Trading
Illinois
– -$216K -8,185 Closed
CCM
74
CAAS Capital Management
New York
– -$108K -4,814 Closed
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
– -$105K -4,701 Closed
1 2
3
4

MRKR Hedge Fund Activity: Q2 2021 in Review

74 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q2 2021, worth a combined $75.8M — up 33% from $56.8M a quarter earlier.

Fund positioning in MRKR was balanced in Q2 2021: 16 funds opened new positions, 16 closed out, 17 added to existing stakes and 25 trimmed.

The largest buyer was Two Sigma Advisers, adding an estimated $3.19M. The largest seller was BlackRock, cutting an estimated $4.79M.

  • 74 institutional investors held Marker Therapeutics (MRKR) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $75.8M of Marker Therapeutics stock for Q2 2021, up 33% quarter-over-quarter.
  • 16 funds opened new Marker Therapeutics positions in Q2 2021 and 16 closed out, a net change of 0 holders.
  • The largest Marker Therapeutics buyer in Q2 2021 was Two Sigma Advisers, an estimated $3.19M added.
  • The largest Marker Therapeutics seller in Q2 2021 was BlackRock, an estimated $4.79M sold.

Based on aggregated 13F filings for Q2 2021.